Articles by Adeline Siew, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Adeline Siew, PhD

Molecular Profiles' New Site Receives MHRA Approval

The new production site is designed to handle a range of non-sterile dosage forms and allow for the manufacture of highly potent compounds.
Jul 12, 2013

Molecular Profiles has opened a new facility in the UK following official approval from MHRA.

Domino Introduces Fast-Drying Ink for High-Speed Coding

The new ink takes less a second to dry and is four times more fade resistant than inks that are typically used in retail packaging.
Jul 12, 2013

The new ink takes less a second to dry and is four times more fade resistant than inks that are typically used in retail packaging.

Seattle Genetics Forms ADC Pact with Bayer

Seattle Genetics could potentially receive approximately $500 million in fees, milestones and royalties.
Jul 3, 2013

Seattle Genetics could potentially receive approximately $500 million in fees, milestones and royalties.

Almac Adds Contained Drug Handling and Bottling Capabilities

Almac introduces handling and bottling capabilities in EU and US headquarters.
Jul 3, 2013

Almac introduces handling and bottling capabilities in EU and US headquarters.

Controlling Drug Release Through Osmotic Systems

Osmotic systems offer versatility for delivering drugs with varied properties and dosage requirements.
Jul 2, 2013

Osmotic systems offer versatility for delivering drugs with varied properties and dosage requirements.

2013 CPhI Pharma Awards Now Open

Entries open to any company across three categories - formulation, process development and best packaging.
Jun 24, 2013

Entries open to any company across three categories - formulation, process development and best packaging.

EC Fines Lundbeck Over 'Pay-for-Delay' Deals in Europe

Lundbeck and eight other pharmaceutical companies have been fined for delaying generic entry of the blockbuster antidepressant, Celexa (citalopram), into the market.
Jun 21, 2013

Lundbeck and eight other pharmaceutical companies have been fined for delaying generic entry of the blockbuster antidepressant, Celexa (citalopram), into the market.

Industry Perspectives: Achieving Solutions for the Challenge of Poorly Water-Soluble Drugs

A multifaceted approach is needed to resolve the myriad of challenges in developing oral formulations of poorly soluble drugs.
Jun 2, 2013

A multifaceted approach is needed to resolve the myriad of challenges in developing oral formulations of poorly soluble drugs.

Amgen and Astellas Form Joint Venture to Address Unmet Medical Needs in Japan

May 29, 2013

Amgen and Astellas have entered into a strategic alliance to provide new medicines for serious unmet medical needs of Japanese patients. The alliance leverages the complementary capabilities of both companies through an innovative business model that combines Amgen's pipeline candidates with Astellas' deep knowledge of Japanese patient and physician needs, long-term commercial and regulatory experience, and strong presence as a leading company in Japan.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here